Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination

Pediatrics

Volumn 97, Issue 5, 1996, Pages 738-739

  Vlacha, ^a,d   Miron, ^b,e   Forman, Edwin N ^d   Peter, Georges ^c,e  

^a H'aemek Hospital ^*  (Greece)

^b HAEMEK MEDICAL CENTER   (Israel)

^c RHODE ISLAND HOSPITAL   (United States)

^d Div of Pediat Hematology Oncology

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CAPILLARY RESISTANCE; CASE REPORT; CHILD; CLINICAL FEATURE; HUMAN; MALE; PETECHIA; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVACCINATION; THROMBOCYTOPENIC PURPURA; VACCINATION;

CHILD; HUMANS; MALE; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; PURPURA; PURPURA, THROMBOCYTOPENIC; RECURRENCE; RUBELLA VACCINE; VACCINES, COMBINED;

EID: 15844422093     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Institute of Medicine. Measles and mumps vaccines. In. Stratton KR, Howe CJ, Johnston RB Jr, eds. Adverse Events Associated With Childhood Vaccines Evidence Bearing on Causality Washington, DC: National Academy Press; 1994;163-169
2. Azeemuddin S. Thrombocytopenia purpura after combined vaccine against measles, mumps, and rubella. Clin Pediatr (Phila) 1987;26:318
3. Sharma ON Thrombocytopenia following measles-mumps-rubella vaccination in a one-year old infant. Clin Pediatr (Phila) 1973;12:315
4. Bottiger M, Christenson B, Romanus V, Taranger J, Strandell A. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella. Br Med J 1987;295:1264-1267
5. Nieminen U, Peltola H, Syrjala MT, Makipernaa A, Kekomaki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr. 1993;82:267-270
6. Oski FA, Naiman JL. Effect of live measles vaccine on the platelet count. N Engl J Med 1963;275:352-356
7. Volpato S, Vigi V, Gappuro D. Thrombocytopenic purpura as the only manifestation of rubella. Lancet 1969;2.1249
8. Hudson JH, Weinstein L, Chang T Thrombocytopenic purpura in measles. J Pediatr. 1956;48:48-56
9. Nasab AR. Thrombocytopenic purpura as a complication of mumps. Clin Pediatr (Phila). 1971;10:420-421
10. Drachtman RA, Murphy S, Ettinger LJ. Exacerbation of chronic idiopathic thrombocytopenic purpura following measles-mumps-rubella immunization. Arch Pediatr Adolesc Med. 1994;148 326-327
11. Peter G. Childhood immunizations. N Engl J Med. 1992;327:1794-1800
12. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): updated sections on vaccine side effects, adverse reactions, contraindications, and precautions. MMWR In press
13. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995;345:567-569